Honoring ALL military veterans of the United States Armed Forces, Aquiline Drones Corporation (AD) – a CT based drone manufacturer and artificial intelligence (AI) systems company has forged a strategic partnership with Ryder System, Inc. and Vets to Drones. Together, they are launching a discounted drone franchise program exclusively for U.S. Veterans – a lifelong opportunity, well beyond 2025! HARTFORD, Conn., Sept. 27, 2025 /PRNewswire-PRWeb/ -- Exciting news in the drone sector as a veteran-owned drone ...

核心事件 - 公司旗下EziAutoJector®无针胰岛素注射产品线获得英国NHS药品目录批准 纳入NHS糖尿病护理报销范围 [1] - 该批准由英国卫生部下属NHS商业服务局确认 通过公司独家英国分销合作伙伴EziAutoJector® Ltd获得 [1] 市场准入与报销机制 - 糖尿病患者经医疗专业人员处方后可免费获得EziAutoJector®设备及配件 费用由NHS承担 [2] - 该安排符合NICE指南关于胰岛素给药方式个性化选择的建议 确保药剂师分发产品时获得报销 [2] 分销渠道建设 - 已通过大型药品批发商建立供应渠道 覆盖线下药店和在线药房直达患者服务 [3] - 设立直接面向消费者(D2C)电子商务渠道 解决部分地区处方限制导致的获取障碍 [4] 市场推广策略 - 在英国市场开展针对糖尿病医疗专业人员、药剂师、患者及护理人员的教育计划 [3] - 通过 awareness提升和 advocacy建设 推动EziAutoJector®产品系列的认知度和使用率 [3] 产品环保优势 - 每名患者转用EziAutoJector®后每年可减少超过1,000支一次性胰岛素针头的使用 [5] - 显著减少生物危害废物及其收集处理过程中的环境足迹 支持NHS环保和成本效率目标 [5] 公司技术背景 - 公司专注于无针皮下给药技术 旗舰产品InsuJet™系统已在42个国家获得批准 [6] - 技术旨在改善全球数百万糖尿病患者的治疗体验和生活质量 [6]

Key Takeaways Ryder has been making uninterrupted dividend payments for more than 49 years.Dividend stocks are safe bets for creating wealth and act as a hedge against economic uncertainty.During the first half of 2025, R paid $71 million through dividends and repurchased shares worth $261 million.Ryder System, Inc. (R) has been consistently making efforts to reward its shareholders through dividends and share buybacks, which are encouraging. In 2022, Ryder paid dividends of $123 million and repurchased sha ...

Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex VirusSeptember 24, 2025 7:00 AM EDT | Source: Theralase Technologies Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, announced today the peer-rev ...

First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay. Originally launc ...

The Zacks  Transportation - Equipment and Leasing industry is currently navigating a challenging macroeconomic environment. The industry grapples with challenges due to persistent inflation, tariff-related tensions and lingering supply-chain disruptions. Geopolitical woes represent further challenges.Despite the challenging macroeconomic conditions, industry players such as Wabtec Corporation (WAB) , Ryder System (R)  and The Greenbrier Companies, Inc. (GBX) ) stand out for their solid investor-friendly ste ...

MARKHAM, ON / ACCESS Newswire / September 22, 2025 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) today announced that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has renewed its license agreement with TUMI, Inc. ("TUMI") to continue integrating IFTNA's PROTX2® antimicrobial solutions across select TUMI products. The renewal extends the relationship first announced on May 5, 2021, by a further period of five years. ...

Inverite Achieves Milestone SOC 2(R) Type II Audit Validation and Data Security ControlsSeptember 18, 2025 8:00 AM EDT | Source: Inverite Insights Inc.Vancouver, British Columbia--(Newsfile Corp. - September 18, 2025) - Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRD) (FSE: 2V0) ("Inverite") is a leading AI-driven software provider utilizing real-time financial data to empower businesses to transact more effectively with consumers, today announced it has successfully completed its SOC 2® T ...

Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market ANN ARBOR, MI / ACCESS Newswire / September 18, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the issuance of four additional ...

IRVINE, CA / ACCESS Newswire / September 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it will file a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a ...